Global and China Nonalcoholic Steatohepatitis (NASH) Market Size, Status and Forecast 2021-2027

Global and China Nonalcoholic Steatohepatitis (NASH) Market Size, Status and Forecast 2021-2027

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Nonalcoholic Steatohepatitis (NASH) Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Obeticholic acid?OCA?
1.2.3 Selonsertib
1.3 Market by Application
1.3.1 Global Nonalcoholic Steatohepatitis (NASH) Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital Pharmacy
1.3.3 Online Provider
1.3.4 Retail Pharmacy
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Nonalcoholic Steatohepatitis (NASH) Market Perspective (2016-2027)
2.2 Nonalcoholic Steatohepatitis (NASH) Growth Trends by Regions
2.2.1 Nonalcoholic Steatohepatitis (NASH) Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Nonalcoholic Steatohepatitis (NASH) Historic Market Share by Regions (2016-2021)
2.2.3 Nonalcoholic Steatohepatitis (NASH) Forecasted Market Size by Regions (2022-2027)
2.3 Nonalcoholic Steatohepatitis (NASH) Industry Dynamic
2.3.1 Nonalcoholic Steatohepatitis (NASH) Market Trends
2.3.2 Nonalcoholic Steatohepatitis (NASH) Market Drivers
2.3.3 Nonalcoholic Steatohepatitis (NASH) Market Challenges
2.3.4 Nonalcoholic Steatohepatitis (NASH) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Nonalcoholic Steatohepatitis (NASH) Players by Revenue
3.1.1 Global Top Nonalcoholic Steatohepatitis (NASH) Players by Revenue (2016-2021)
3.1.2 Global Nonalcoholic Steatohepatitis (NASH) Revenue Market Share by Players (2016-2021)
3.2 Global Nonalcoholic Steatohepatitis (NASH) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Nonalcoholic Steatohepatitis (NASH) Revenue
3.4 Global Nonalcoholic Steatohepatitis (NASH) Market Concentration Ratio
3.4.1 Global Nonalcoholic Steatohepatitis (NASH) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Nonalcoholic Steatohepatitis (NASH) Revenue in 2020
3.5 Nonalcoholic Steatohepatitis (NASH) Key Players Head office and Area Served
3.6 Key Players Nonalcoholic Steatohepatitis (NASH) Product Solution and Service
3.7 Date of Enter into Nonalcoholic Steatohepatitis (NASH) Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Nonalcoholic Steatohepatitis (NASH) Breakdown Data by Type
4.1 Global Nonalcoholic Steatohepatitis (NASH) Historic Market Size by Type (2016-2021)
4.2 Global Nonalcoholic Steatohepatitis (NASH) Forecasted Market Size by Type (2022-2027)
5 Nonalcoholic Steatohepatitis (NASH) Breakdown Data by Application
5.1 Global Nonalcoholic Steatohepatitis (NASH) Historic Market Size by Application (2016-2021)
5.2 Global Nonalcoholic Steatohepatitis (NASH) Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Nonalcoholic Steatohepatitis (NASH) Market Size (2016-2027)
6.2 North America Nonalcoholic Steatohepatitis (NASH) Market Size by Type
6.2.1 North America Nonalcoholic Steatohepatitis (NASH) Market Size by Type (2016-2021)
6.2.2 North America Nonalcoholic Steatohepatitis (NASH) Market Size by Type (2022-2027)
6.2.3 North America Nonalcoholic Steatohepatitis (NASH) Market Size by Type (2016-2027)
6.3 North America Nonalcoholic Steatohepatitis (NASH) Market Size by Application
6.3.1 North America Nonalcoholic Steatohepatitis (NASH) Market Size by Application (2016-2021)
6.3.2 North America Nonalcoholic Steatohepatitis (NASH) Market Size by Application (2022-2027)
6.3.3 North America Nonalcoholic Steatohepatitis (NASH) Market Size by Application (2016-2027)
6.4 North America Nonalcoholic Steatohepatitis (NASH) Market Size by Country
6.4.1 North America Nonalcoholic Steatohepatitis (NASH) Market Size by Country (2016-2021)
6.4.2 North America Nonalcoholic Steatohepatitis (NASH) Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Nonalcoholic Steatohepatitis (NASH) Market Size (2016-2027)
7.2 Europe Nonalcoholic Steatohepatitis (NASH) Market Size by Type
7.2.1 Europe Nonalcoholic Steatohepatitis (NASH) Market Size by Type (2016-2021)
7.2.2 Europe Nonalcoholic Steatohepatitis (NASH) Market Size by Type (2022-2027)
7.2.3 Europe Nonalcoholic Steatohepatitis (NASH) Market Size by Type (2016-2027)
7.3 Europe Nonalcoholic Steatohepatitis (NASH) Market Size by Application
7.3.1 Europe Nonalcoholic Steatohepatitis (NASH) Market Size by Application (2016-2021)
7.3.2 Europe Nonalcoholic Steatohepatitis (NASH) Market Size by Application (2022-2027)
7.3.3 Europe Nonalcoholic Steatohepatitis (NASH) Market Size by Application (2016-2027)
7.4 Europe Nonalcoholic Steatohepatitis (NASH) Market Size by Country
7.4.1 Europe Nonalcoholic Steatohepatitis (NASH) Market Size by Country (2016-2021)
7.4.2 Europe Nonalcoholic Steatohepatitis (NASH) Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Nonalcoholic Steatohepatitis (NASH) Market Size (2016-2027)
8.2 Asia-Pacific Nonalcoholic Steatohepatitis (NASH) Market Size by Type
8.2.1 Asia-Pacific Nonalcoholic Steatohepatitis (NASH) Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Nonalcoholic Steatohepatitis (NASH) Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Nonalcoholic Steatohepatitis (NASH) Market Size by Type (2016-2027)
8.3 Asia-Pacific Nonalcoholic Steatohepatitis (NASH) Market Size by Application
8.3.1 Asia-Pacific Nonalcoholic Steatohepatitis (NASH) Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Nonalcoholic Steatohepatitis (NASH) Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Nonalcoholic Steatohepatitis (NASH) Market Size by Application (2016-2027)
8.4 Asia-Pacific Nonalcoholic Steatohepatitis (NASH) Market Size by Region
8.4.1 Asia-Pacific Nonalcoholic Steatohepatitis (NASH) Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Nonalcoholic Steatohepatitis (NASH) Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Nonalcoholic Steatohepatitis (NASH) Market Size (2016-2027)
9.2 Latin America Nonalcoholic Steatohepatitis (NASH) Market Size by Type
9.2.1 Latin America Nonalcoholic Steatohepatitis (NASH) Market Size by Type (2016-2021)
9.2.2 Latin America Nonalcoholic Steatohepatitis (NASH) Market Size by Type (2022-2027)
9.2.3 Latin America Nonalcoholic Steatohepatitis (NASH) Market Size by Type (2016-2027)
9.3 Latin America Nonalcoholic Steatohepatitis (NASH) Market Size by Application
9.3.1 Latin America Nonalcoholic Steatohepatitis (NASH) Market Size by Application (2016-2021)
9.3.2 Latin America Nonalcoholic Steatohepatitis (NASH) Market Size by Application (2022-2027)
9.3.3 Latin America Nonalcoholic Steatohepatitis (NASH) Market Size by Application (2016-2027)
9.4 Latin America Nonalcoholic Steatohepatitis (NASH) Market Size by Country
9.4.1 Latin America Nonalcoholic Steatohepatitis (NASH) Market Size by Country (2016-2021)
9.4.2 Latin America Nonalcoholic Steatohepatitis (NASH) Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Nonalcoholic Steatohepatitis (NASH) Market Size (2016-2027)
10.2 Middle East & Africa Nonalcoholic Steatohepatitis (NASH) Market Size by Type
10.2.1 Middle East & Africa Nonalcoholic Steatohepatitis (NASH) Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Nonalcoholic Steatohepatitis (NASH) Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Nonalcoholic Steatohepatitis (NASH) Market Size by Type (2016-2027)
10.3 Middle East & Africa Nonalcoholic Steatohepatitis (NASH) Market Size by Application
10.3.1 Middle East & Africa Nonalcoholic Steatohepatitis (NASH) Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Nonalcoholic Steatohepatitis (NASH) Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Nonalcoholic Steatohepatitis (NASH) Market Size by Application (2016-2027)
10.4 Middle East & Africa Nonalcoholic Steatohepatitis (NASH) Market Size by Country
10.4.1 Middle East & Africa Nonalcoholic Steatohepatitis (NASH) Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Nonalcoholic Steatohepatitis (NASH) Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 AstraZeneca
11.1.1 AstraZeneca Company Details
11.1.2 AstraZeneca Business Overview
11.1.3 AstraZeneca Nonalcoholic Steatohepatitis (NASH) Introduction
11.1.4 AstraZeneca Revenue in Nonalcoholic Steatohepatitis (NASH) Business (2016-2021)
11.1.5 AstraZeneca Recent Development
11.2 Arena Pharmaceuticals
11.2.1 Arena Pharmaceuticals Company Details
11.2.2 Arena Pharmaceuticals Business Overview
11.2.3 Arena Pharmaceuticals Nonalcoholic Steatohepatitis (NASH) Introduction
11.2.4 Arena Pharmaceuticals Revenue in Nonalcoholic Steatohepatitis (NASH) Business (2016-2021)
11.2.5 Arena Pharmaceuticals Recent Development
11.3 GSK
11.3.1 GSK Company Details
11.3.2 GSK Business Overview
11.3.3 GSK Nonalcoholic Steatohepatitis (NASH) Introduction
11.3.4 GSK Revenue in Nonalcoholic Steatohepatitis (NASH) Business (2016-2021)
11.3.5 GSK Recent Development
11.4 Novo Nordisk
11.4.1 Novo Nordisk Company Details
11.4.2 Novo Nordisk Business Overview
11.4.3 Novo Nordisk Nonalcoholic Steatohepatitis (NASH) Introduction
11.4.4 Novo Nordisk Revenue in Nonalcoholic Steatohepatitis (NASH) Business (2016-2021)
11.4.5 Novo Nordisk Recent Development
11.5 Roche
11.5.1 Roche Company Details
11.5.2 Roche Business Overview
11.5.3 Roche Nonalcoholic Steatohepatitis (NASH) Introduction
11.5.4 Roche Revenue in Nonalcoholic Steatohepatitis (NASH) Business (2016-2021)
11.5.5 Roche Recent Development
11.6 Vivus
11.6.1 Vivus Company Details
11.6.2 Vivus Business Overview
11.6.3 Vivus Nonalcoholic Steatohepatitis (NASH) Introduction
11.6.4 Vivus Revenue in Nonalcoholic Steatohepatitis (NASH) Business (2016-2021)
11.6.5 Vivus Recent Development
11.7 Arisaph Pharmaceuticals
11.7.1 Arisaph Pharmaceuticals Company Details
11.7.2 Arisaph Pharmaceuticals Business Overview
11.7.3 Arisaph Pharmaceuticals Nonalcoholic Steatohepatitis (NASH) Introduction
11.7.4 Arisaph Pharmaceuticals Revenue in Nonalcoholic Steatohepatitis (NASH) Business (2016-2021)
11.7.5 Arisaph Pharmaceuticals Recent Development
11.8 Cempra Pharmaceuticals
11.8.1 Cempra Pharmaceuticals Company Details
11.8.2 Cempra Pharmaceuticals Business Overview
11.8.3 Cempra Pharmaceuticals Nonalcoholic Steatohepatitis (NASH) Introduction
11.8.4 Cempra Pharmaceuticals Revenue in Nonalcoholic Steatohepatitis (NASH) Business (2016-2021)
11.8.5 Cempra Pharmaceuticals Recent Development
11.9 Galectin Therapeutics
11.9.1 Galectin Therapeutics Company Details
11.9.2 Galectin Therapeutics Business Overview
11.9.3 Galectin Therapeutics Nonalcoholic Steatohepatitis (NASH) Introduction
11.9.4 Galectin Therapeutics Revenue in Nonalcoholic Steatohepatitis (NASH) Business (2016-2021)
11.9.5 Galectin Therapeutics Recent Development
11.10 Galmed Pharmaceuticals
11.10.1 Galmed Pharmaceuticals Company Details
11.10.2 Galmed Pharmaceuticals Business Overview
11.10.3 Galmed Pharmaceuticals Nonalcoholic Steatohepatitis (NASH) Introduction
11.10.4 Galmed Pharmaceuticals Revenue in Nonalcoholic Steatohepatitis (NASH) Business (2016-2021)
11.10.5 Galmed Pharmaceuticals Recent Development
11.11 Genfit
11.11.1 Genfit Company Details
11.11.2 Genfit Business Overview
11.11.3 Genfit Nonalcoholic Steatohepatitis (NASH) Introduction
11.11.4 Genfit Revenue in Nonalcoholic Steatohepatitis (NASH) Business (2016-2021)
11.11.5 Genfit Recent Development
11.12 Gilead
11.12.1 Gilead Company Details
11.12.2 Gilead Business Overview
11.12.3 Gilead Nonalcoholic Steatohepatitis (NASH) Introduction
11.12.4 Gilead Revenue in Nonalcoholic Steatohepatitis (NASH) Business (2016-2021)
11.12.5 Gilead Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Nonalcoholic Steatohepatitis (NASH) Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Obeticholic acid?OCA?
Table 3. Key Players of Selonsertib
Table 4. Global Nonalcoholic Steatohepatitis (NASH) Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Nonalcoholic Steatohepatitis (NASH) Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Nonalcoholic Steatohepatitis (NASH) Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Nonalcoholic Steatohepatitis (NASH) Market Share by Regions (2016-2021)
Table 8. Global Nonalcoholic Steatohepatitis (NASH) Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Nonalcoholic Steatohepatitis (NASH) Market Share by Regions (2022-2027)
Table 10. Nonalcoholic Steatohepatitis (NASH) Market Trends
Table 11. Nonalcoholic Steatohepatitis (NASH) Market Drivers
Table 12. Nonalcoholic Steatohepatitis (NASH) Market Challenges
Table 13. Nonalcoholic Steatohepatitis (NASH) Market Restraints
Table 14. Global Nonalcoholic Steatohepatitis (NASH) Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Nonalcoholic Steatohepatitis (NASH) Market Share by Players (2016-2021)
Table 16. Global Top Nonalcoholic Steatohepatitis (NASH) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Nonalcoholic Steatohepatitis (NASH) as of 2020)
Table 17. Ranking of Global Top Nonalcoholic Steatohepatitis (NASH) Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Nonalcoholic Steatohepatitis (NASH) Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Nonalcoholic Steatohepatitis (NASH) Product Solution and Service
Table 21. Date of Enter into Nonalcoholic Steatohepatitis (NASH) Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Nonalcoholic Steatohepatitis (NASH) Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Nonalcoholic Steatohepatitis (NASH) Revenue Market Share by Type (2016-2021)
Table 25. Global Nonalcoholic Steatohepatitis (NASH) Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Nonalcoholic Steatohepatitis (NASH) Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Nonalcoholic Steatohepatitis (NASH) Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Nonalcoholic Steatohepatitis (NASH) Revenue Market Share by Application (2016-2021)
Table 29. Global Nonalcoholic Steatohepatitis (NASH) Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Nonalcoholic Steatohepatitis (NASH) Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Nonalcoholic Steatohepatitis (NASH) Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Nonalcoholic Steatohepatitis (NASH) Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Nonalcoholic Steatohepatitis (NASH) Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Nonalcoholic Steatohepatitis (NASH) Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Nonalcoholic Steatohepatitis (NASH) Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Nonalcoholic Steatohepatitis (NASH) Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Nonalcoholic Steatohepatitis (NASH) Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Nonalcoholic Steatohepatitis (NASH) Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Nonalcoholic Steatohepatitis (NASH) Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Nonalcoholic Steatohepatitis (NASH) Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Nonalcoholic Steatohepatitis (NASH) Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Nonalcoholic Steatohepatitis (NASH) Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Nonalcoholic Steatohepatitis (NASH) Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Nonalcoholic Steatohepatitis (NASH) Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Nonalcoholic Steatohepatitis (NASH) Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Nonalcoholic Steatohepatitis (NASH) Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Nonalcoholic Steatohepatitis (NASH) Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Nonalcoholic Steatohepatitis (NASH) Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Nonalcoholic Steatohepatitis (NASH) Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Nonalcoholic Steatohepatitis (NASH) Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Nonalcoholic Steatohepatitis (NASH) Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Nonalcoholic Steatohepatitis (NASH) Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Nonalcoholic Steatohepatitis (NASH) Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Nonalcoholic Steatohepatitis (NASH) Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Nonalcoholic Steatohepatitis (NASH) Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Nonalcoholic Steatohepatitis (NASH) Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Nonalcoholic Steatohepatitis (NASH) Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Nonalcoholic Steatohepatitis (NASH) Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Nonalcoholic Steatohepatitis (NASH) Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Nonalcoholic Steatohepatitis (NASH) Market Size by Country (2022-2027) & (US$ Million)
Table 61. AstraZeneca Company Details
Table 62. AstraZeneca Business Overview
Table 63. AstraZeneca Nonalcoholic Steatohepatitis (NASH) Product
Table 64. AstraZeneca Revenue in Nonalcoholic Steatohepatitis (NASH) Business (2016-2021) & (US$ Million)
Table 65. AstraZeneca Recent Development
Table 66. Arena Pharmaceuticals Company Details
Table 67. Arena Pharmaceuticals Business Overview
Table 68. Arena Pharmaceuticals Nonalcoholic Steatohepatitis (NASH) Product
Table 69. Arena Pharmaceuticals Revenue in Nonalcoholic Steatohepatitis (NASH) Business (2016-2021) & (US$ Million)
Table 70. Arena Pharmaceuticals Recent Development
Table 71. GSK Company Details
Table 72. GSK Business Overview
Table 73. GSK Nonalcoholic Steatohepatitis (NASH) Product
Table 74. GSK Revenue in Nonalcoholic Steatohepatitis (NASH) Business (2016-2021) & (US$ Million)
Table 75. GSK Recent Development
Table 76. Novo Nordisk Company Details
Table 77. Novo Nordisk Business Overview
Table 78. Novo Nordisk Nonalcoholic Steatohepatitis (NASH) Product
Table 79. Novo Nordisk Revenue in Nonalcoholic Steatohepatitis (NASH) Business (2016-2021) & (US$ Million)
Table 80. Novo Nordisk Recent Development
Table 81. Roche Company Details
Table 82. Roche Business Overview
Table 83. Roche Nonalcoholic Steatohepatitis (NASH) Product
Table 84. Roche Revenue in Nonalcoholic Steatohepatitis (NASH) Business (2016-2021) & (US$ Million)
Table 85. Roche Recent Development
Table 86. Vivus Company Details
Table 87. Vivus Business Overview
Table 88. Vivus Nonalcoholic Steatohepatitis (NASH) Product
Table 89. Vivus Revenue in Nonalcoholic Steatohepatitis (NASH) Business (2016-2021) & (US$ Million)
Table 90. Vivus Recent Development
Table 91. Arisaph Pharmaceuticals Company Details
Table 92. Arisaph Pharmaceuticals Business Overview
Table 93. Arisaph Pharmaceuticals Nonalcoholic Steatohepatitis (NASH) Product
Table 94. Arisaph Pharmaceuticals Revenue in Nonalcoholic Steatohepatitis (NASH) Business (2016-2021) & (US$ Million)
Table 95. Arisaph Pharmaceuticals Recent Development
Table 96. Cempra Pharmaceuticals Company Details
Table 97. Cempra Pharmaceuticals Business Overview
Table 98. Cempra Pharmaceuticals Revenue in Nonalcoholic Steatohepatitis (NASH) Business (2016-2021) & (US$ Million)
Table 99. Cempra Pharmaceuticals Recent Development
Table 100. Galectin Therapeutics Company Details
Table 101. Galectin Therapeutics Business Overview
Table 102. Galectin Therapeutics Nonalcoholic Steatohepatitis (NASH) Product
Table 103. Galectin Therapeutics Revenue in Nonalcoholic Steatohepatitis (NASH) Business (2016-2021) & (US$ Million)
Table 104. Galectin Therapeutics Recent Development
Table 105. Galmed Pharmaceuticals Company Details
Table 106. Galmed Pharmaceuticals Business Overview
Table 107. Galmed Pharmaceuticals Nonalcoholic Steatohepatitis (NASH) Product
Table 108. Galmed Pharmaceuticals Revenue in Nonalcoholic Steatohepatitis (NASH) Business (2016-2021) & (US$ Million)
Table 109. Galmed Pharmaceuticals Recent Development
Table 110. Genfit Company Details
Table 111. Genfit Business Overview
Table 112. Genfit Nonalcoholic Steatohepatitis (NASH) Product
Table 113. Genfit Revenue in Nonalcoholic Steatohepatitis (NASH) Business (2016-2021) & (US$ Million)
Table 114. Genfit Recent Development
Table 115. Gilead Company Details
Table 116. Gilead Business Overview
Table 117. Gilead Nonalcoholic Steatohepatitis (NASH) Product
Table 118. Gilead Revenue in Nonalcoholic Steatohepatitis (NASH) Business (2016-2021) & (US$ Million)
Table 119. Gilead Recent Development
Table 120. Research Programs/Design for This Report
Table 121. Key Data Information from Secondary Sources
Table 122. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Nonalcoholic Steatohepatitis (NASH) Market Share by Type: 2020 VS 2027
Figure 2. Obeticholic acid?OCA? Features
Figure 3. Selonsertib Features
Figure 4. Global Nonalcoholic Steatohepatitis (NASH) Market Share by Application: 2020 VS 2027
Figure 5. Hospital Pharmacy Case Studies
Figure 6. Online Provider Case Studies
Figure 7. Retail Pharmacy Case Studies
Figure 8. Nonalcoholic Steatohepatitis (NASH) Report Years Considered
Figure 9. Global Nonalcoholic Steatohepatitis (NASH) Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Nonalcoholic Steatohepatitis (NASH) Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Nonalcoholic Steatohepatitis (NASH) Market Share by Regions: 2020 VS 2027
Figure 12. Global Nonalcoholic Steatohepatitis (NASH) Market Share by Regions (2022-2027)
Figure 13. Global Nonalcoholic Steatohepatitis (NASH) Market Share by Players in 2020
Figure 14. Global Top Nonalcoholic Steatohepatitis (NASH) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Nonalcoholic Steatohepatitis (NASH) as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Nonalcoholic Steatohepatitis (NASH) Revenue in 2020
Figure 16. Global Nonalcoholic Steatohepatitis (NASH) Revenue Market Share by Type (2016-2021)
Figure 17. Global Nonalcoholic Steatohepatitis (NASH) Revenue Market Share by Type (2022-2027)
Figure 18. North America Nonalcoholic Steatohepatitis (NASH) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Nonalcoholic Steatohepatitis (NASH) Market Share by Type (2016-2027)
Figure 20. North America Nonalcoholic Steatohepatitis (NASH) Market Share by Application (2016-2027)
Figure 21. North America Nonalcoholic Steatohepatitis (NASH) Market Share by Country (2016-2027)
Figure 22. United States Nonalcoholic Steatohepatitis (NASH) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Nonalcoholic Steatohepatitis (NASH) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Nonalcoholic Steatohepatitis (NASH) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Nonalcoholic Steatohepatitis (NASH) Market Share by Type (2016-2027)
Figure 26. Europe Nonalcoholic Steatohepatitis (NASH) Market Share by Application (2016-2027)
Figure 27. Europe Nonalcoholic Steatohepatitis (NASH) Market Share by Country (2016-2027)
Figure 28. Germany Nonalcoholic Steatohepatitis (NASH) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Nonalcoholic Steatohepatitis (NASH) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Nonalcoholic Steatohepatitis (NASH) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Nonalcoholic Steatohepatitis (NASH) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Nonalcoholic Steatohepatitis (NASH) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Nonalcoholic Steatohepatitis (NASH) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Nonalcoholic Steatohepatitis (NASH) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Nonalcoholic Steatohepatitis (NASH) Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Nonalcoholic Steatohepatitis (NASH) Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Nonalcoholic Steatohepatitis (NASH) Market Share by Region (2016-2027)
Figure 38. China Nonalcoholic Steatohepatitis (NASH) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Nonalcoholic Steatohepatitis (NASH) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Nonalcoholic Steatohepatitis (NASH) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Nonalcoholic Steatohepatitis (NASH) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Nonalcoholic Steatohepatitis (NASH) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Nonalcoholic Steatohepatitis (NASH) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Nonalcoholic Steatohepatitis (NASH) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Nonalcoholic Steatohepatitis (NASH) Market Share by Type (2016-2027)
Figure 46. Latin America Nonalcoholic Steatohepatitis (NASH) Market Share by Application (2016-2027)
Figure 47. Latin America Nonalcoholic Steatohepatitis (NASH) Market Share by Country (2016-2027)
Figure 48. Mexico Nonalcoholic Steatohepatitis (NASH) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Nonalcoholic Steatohepatitis (NASH) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Nonalcoholic Steatohepatitis (NASH) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Nonalcoholic Steatohepatitis (NASH) Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Nonalcoholic Steatohepatitis (NASH) Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Nonalcoholic Steatohepatitis (NASH) Market Share by Country (2016-2027)
Figure 54. Turkey Nonalcoholic Steatohepatitis (NASH) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Nonalcoholic Steatohepatitis (NASH) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Nonalcoholic Steatohepatitis (NASH) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. AstraZeneca Revenue Growth Rate in Nonalcoholic Steatohepatitis (NASH) Business (2016-2021)
Figure 58. Arena Pharmaceuticals Revenue Growth Rate in Nonalcoholic Steatohepatitis (NASH) Business (2016-2021)
Figure 59. GSK Revenue Growth Rate in Nonalcoholic Steatohepatitis (NASH) Business (2016-2021)
Figure 60. Novo Nordisk Revenue Growth Rate in Nonalcoholic Steatohepatitis (NASH) Business (2016-2021)
Figure 61. Roche Revenue Growth Rate in Nonalcoholic Steatohepatitis (NASH) Business (2016-2021)
Figure 62. Vivus Revenue Growth Rate in Nonalcoholic Steatohepatitis (NASH) Business (2016-2021)
Figure 63. Arisaph Pharmaceuticals Revenue Growth Rate in Nonalcoholic Steatohepatitis (NASH) Business (2016-2021)
Figure 64. Cempra Pharmaceuticals Revenue Growth Rate in Nonalcoholic Steatohepatitis (NASH) Business (2016-2021)
Figure 65. Galectin Therapeutics Revenue Growth Rate in Nonalcoholic Steatohepatitis (NASH) Business (2016-2021)
Figure 66. Galmed Pharmaceuticals Revenue Growth Rate in Nonalcoholic Steatohepatitis (NASH) Business (2016-2021)
Figure 67. Genfit Revenue Growth Rate in Nonalcoholic Steatohepatitis (NASH) Business (2016-2021)
Figure 68. Gilead Revenue Growth Rate in Nonalcoholic Steatohepatitis (NASH) Business (2016-2021)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029

Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118

The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......

Global Non-imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95

The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90

The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......

Global PCR Equipment Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77

The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......

Global Disposable Sterile Syringes and Needles Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109

The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......

Global Orthopaedic Power Tools Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......

Global Cerebrospinal Fluid Management Devices Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......

Global CAD & CAM Milling Burs Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79

The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......

Global Artificial Teeth Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98

The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs